Trump administration moves to ease federal restrictions on marijuana
Quick Insights
The Bottom Line
The Trump administration moved to reclassify marijuana from schedule I to schedule III.
How This Affects You
This reclassification could expand medical access to marijuana and facilitate more research into its uses.
AI Summary
The Trump administration has moved to reclassify marijuana from schedule I to schedule III under the Controlled Substances Act. This action follows President Donald Trump's executive order, signed more than four months prior, directing the attorney general to initiate the change. Previously, marijuana shared the same schedule I classification as drugs like heroin and LSD, indicating a high potential for abuse and no accepted medical use. The reclassification to schedule III acknowledges some medical use and a lower potential for abuse, marking a significant shift in federal drug policy. This change could impact research, medical access, and federal enforcement related to cannabis.
What's Being Done
President Trump's executive order directed the attorney general to initiate the change.
Source Coverage Map
13 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Trump Administration's Psychedelic Drug Research Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, including psilocybin and ibogaine. This initiative aims to expand access to these therapies, with podcaster Joe Rogan reportedly influencing the decision.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump signed an executive order to accelerate research and review of psychedelic drugs like psilocybin and ibogaine for mental health treatments. This move aims to fast-track their potential medical applications, with figures like Joe Rogan joining the announcement.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump has signed an executive order to fast-track the review and research of psychedelic drugs for mental health disorders. This move aims to accelerate access to treatments like psilocybin and ibogaine, with the President publicly endorsing their potential.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order aimed at accelerating the federal review process for psychedelics. The order seeks to expand access to psychedelic drug treatments for mental health, specifically mentioning substances like ibogaine, LSD, and psilocybin.
Trump's Psychedelics Research Initiative
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics like ibogaine, LSD, and psilocybin for potential medical applications, particularly in mental health treatment. The initiative aims to expand access to these substances and expedite their review process.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics, including ibogaine, LSD, and psilocybin, for mental health treatments. This move aims to expand access to these substances and expedite their review process.
Trump Administration's Psychedelic Drug Initiative
President Trump signed an executive order to accelerate access to psychedelic drug treatments and research for mental health. This initiative aims to expand the availability of substances like LSD, psilocybin, and ibogaine for medical use.
Trump Administration's Push for Psychedelic Drug Treatments
President Donald Trump has signed an executive order to accelerate access to and research into psychedelic drug treatments. This move aims to expand the availability of substances like LSD, psilocybin, and ibogaine for mental health treatment and research.
Trump Administration's Reclassification of Marijuana
The Trump administration has reclassified state-licensed medical marijuana from Schedule I to Schedule III under the Controlled Substances Act, a move that significantly eases restrictions and could impact future legalization efforts.
Trump Administration Reclassifies Marijuana
The Trump administration has reclassified state-licensed medical marijuana as a 'less-dangerous drug,' moving it from Schedule I to Schedule III under the Controlled Substances Act. This significant policy shift is expected to ease research barriers and impact the growing cannabis industry.
Civil Rights & Justice
Following developments in civil rights, criminal justice reform, voting rights, Supreme Court decisions, policing accountability, and the ongoing struggle for equality and justice across American institutions.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
EnvironmentFederal judge blocks Trump administration restrictions on wind and solar projects
<p>The injunction pauses policy giving senior Trump official direct sign-off on federal clean energy projects</p><p>A federal judge in Massachusetts on Tuesday struck down several <a href="https://www.theguardian.com/us-news/trump-administration">Trump administration</a> actions slowing down development of clean energy, including a requirement that all solar and wind energy projects on federal lands and waters be personally approved by the interior secretary, Doug Burgum.</p><p>Denise J Casper, chief judge of the US district court for Massachusetts, ruled that a coalition of plaintiffs representing wind and solar developers were likely to succeed on the merits of their claims that the administration’s actions violate federal statute and will cause irreparable harm if the court did not intervene.</p> <a href="https://www.theguardian.com/us-news/2026/apr/22/trump-wind-solar-clean-energy-order">Continue reading...</a>
PoliticsScoop: Trump set to reclassify marijuana soon
<p>The <a href="https://www.axios.com/politics-policy/donald-trump" target="_blank">Trump</a> administration is expected to move to <a href="https://www.axios.com/2025/12/18/trump-reclassify-marijuana-weed-schedule-drugs" target="_blank">reclassify</a> marijuana as soon as Wednesday, per an administration official familiar with the matter.</p><p><strong>Why it matters: </strong>The move would make it easier to study medicinal applications of marijuana and could shore up support from <a href="https://www.axios.com/2026/04/20/trump-woos-rogan-after-split" target="_blank">influencers</a> who support the research.</p><hr><ul><li>The move follows an executive order from the president last year to reclassify marijuana as a Schedule III drug, which is a years-long process. </li></ul><p><strong>How it works: </strong><a href="https://www.axios.com/2025/12/12/trump-marijuana-federal-restrictions-reclassify" target="_blank">Reclassifying</a> marijuana eases U.S. Drug Enforcement Administratio...
PoliticsTrump administration to release Second Avenue subway funding after MTA lawsuit
The Trump administration on Thursday agreed to release federal funding to go toward the New York’s Metropolitan Transportation Authority (MTA) project to extend the Second Avenue subway following a lawsuit to restore funding for the extension. A Department of Transportation (DOT) spokesperson told The Hill that President Trump and Transportation Secretary Sean Duffy agreed to…
HealthTrump administration moves forward with certain drug reclassifications
President Trump signed an executive order on Saturday that paves the way for more research into psychedelics as treatment for certain mental illnesses. The signing follows Mr. Trump's move in December 2025 to reclassify marijuana as a less dangerous drug. Josh Kesselman, the founder of RAW rolling papers and publisher of High Times Magazine, joins with more.
PoliticsTrump administration flies 10-year-old back from Cuba amid custody fight involving gender identity - AP News
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQNS1kN2pjQ2VCbms1NjZEVmE0MWhEZTExYUphMWFZZ2QwZ254bmpTMVJoY3hXZnlqdE9udHZGcmxpYi1NX3RYTnFFU1VuM3JQTG13WXlGd200emJYSWRjbkRQa3JYMTBPdjFjRlE1NmQ4VElKTkVzQ3hlb2pZVVVKU1ZzQzNtZzdzcEFDZG9nYWQ2LWRRdEk0bVBXcy04aGp6T0E?oc=5" target="_blank">Trump administration flies 10-year-old back from Cuba amid custody fight involving gender identity</a> <font color="#6f6f6f">AP News</font>
PoliticsThe Trump administration revisits the Russia scandal - Politico
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxNdzNIYmtWVEFlVGp4dFNXLWQyd1BxSGVwdzloVHNYaWdYQkJVZUg3NjV5MWxYNWVaUG5zLW00RTdCc25Dcnl5Qk4yZ2x3VTJkX3hYWnEtX3BZODhId2ZiLS1lSmhTazg0V2NpekRydFNndWJLN1dEQTJIOERBUkowM19SVmhMOXRjaGlhZw?oc=5" target="_blank">The Trump administration revisits the Russia scandal</a> <font color="#6f6f6f">Politico</font>
Trump reclassifies state-licensed medical marijuana as less-dangerous drug
The order signed by Todd Blanche does not legalize marijuana for medical or recreational use under federal law. But it does change the way it's regulated.
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
One in three Americans forced to make financial sacrifices for health coverage
Trump-branded data center project CEO departs
6 crew still missing after overturned ship that disappeared after typhoon is found near Saipan - AP News
US Live Nation and Ticketmaster verdict triggers calls for Australian investigation into ticketing rules
